IL6 and cancer: Cancer-related muscle wasting has been attributed to circulating, i.e., systemic inflammatory, prooxidative, or other catabolic factors of tumor or multiple host origins [9,10,11,12,13], such as TNF, IL6, PIF, ZAG, or the more recently identified IL8 [14] or MyD88 [15].